Financial Ratios HDFC Life Insurance Company Limited
Equities
HDFCLIFE
INE795G01014
Life & Health Insurance
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
786.30 INR | -0.99% |
|
-2.91% | +27.43% |
02/07 | India's Max Financial reports cyber threat at unit | RE |
02/07 | Financials Drag Indian Markets Lower on Wednesday Despite Optimism Over India-US Trade Deal | MT |
Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.67 | 0.47 | 0.39 | 0.24 | 0.27 | |||||
Return on Total Capital | 13.04 | 7.63 | 6.23 | 4.42 | 5.07 | |||||
Return On Equity % | 17.62 | 10.94 | 9.57 | 11.38 | 11.75 | |||||
Return on Common Equity | 17.62 | 10.94 | 9.57 | 11.38 | 11.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 9.23 | 11.56 | 14.71 | 8.3 | 8.47 | |||||
SG&A Margin | 6.26 | 8.52 | 11.77 | 6.66 | 6.3 | |||||
EBITDA Margin % | 2.36 | 2.34 | 2.19 | 1.07 | 1.52 | |||||
EBITA Margin % | 2.33 | 2.3 | 2.12 | 1.03 | 1.45 | |||||
EBIT Margin % | 2.33 | 2.3 | 2.12 | 1.03 | 1.45 | |||||
Income From Continuing Operations Margin % | 1.89 | 1.96 | 1.93 | 1.54 | 1.86 | |||||
Net Income Margin % | 1.89 | 1.96 | 1.93 | 1.54 | 1.86 | |||||
Net Avail. For Common Margin % | 1.89 | 1.96 | 1.93 | 1.54 | 1.86 | |||||
Normalized Net Income Margin | 1.41 | 1.37 | 1.27 | 0.6 | 0.83 | |||||
Levered Free Cash Flow Margin | 2.36 | 1.14 | 2.02 | 0.6 | -1.69 | |||||
Unlevered Free Cash Flow Margin | 2.4 | 1.2 | 2.08 | 0.65 | -1.62 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.46 | 0.33 | 0.3 | 0.37 | 0.3 | |||||
Fixed Assets Turnover | 241.89 | 221.31 | 222.48 | 305 | 216.27 | |||||
Receivables Turnover (Average Receivables) | 159.66 | 117.21 | 104.91 | 82.29 | 64.48 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.92 | 0.99 | 0.91 | 0.95 | 1.22 | |||||
Quick Ratio | 0.38 | 0.39 | 0.29 | 0.36 | 0.53 | |||||
Operating Cash Flow to Current Liabilities | 1.48 | 0.86 | 0.84 | 1.21 | 1.61 | |||||
Days Sales Outstanding (Average Receivables) | 2.29 | 3.11 | 3.48 | 4.45 | 5.66 | |||||
Average Days Payable Outstanding | 26.07 | 33.11 | 34.56 | 22.21 | 21.48 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.94 | 3.84 | 7.31 | 6.48 | 18.26 | |||||
Total Debt / Total Capital | 6.49 | 3.7 | 6.81 | 6.08 | 15.44 | |||||
LT Debt/Equity | 6.94 | 3.84 | 7.31 | 6.48 | 18.26 | |||||
Long-Term Debt / Total Capital | 6.49 | 3.7 | 6.81 | 6.08 | 15.44 | |||||
Total Liabilities / Total Assets | 95.19 | 93.23 | 94.76 | 95.15 | 95.38 | |||||
EBIT / Interest Expense | 36.83 | 23.67 | 24.17 | 15.18 | 12.03 | |||||
EBITDA / Interest Expense | 37.43 | 24.1 | 24.88 | 15.79 | 12.6 | |||||
(EBITDA - Capex) / Interest Expense | 36.08 | 23.23 | 23.47 | 13.82 | 10.04 | |||||
Total Debt / EBITDA | 0.35 | 0.38 | 0.61 | 0.87 | 2 | |||||
Net Debt / EBITDA | -0.29 | -0.49 | -0.14 | -0.56 | 0.76 | |||||
Total Debt / (EBITDA - Capex) | 0.37 | 0.39 | 0.65 | 1 | 2.51 | |||||
Net Debt / (EBITDA - Capex) | -0.3 | -0.51 | -0.15 | -0.64 | 0.96 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 148.61 | -6 | 4.65 | 44.07 | -4.68 | |||||
Gross Profit, 1 Yr. Growth % | 8.5 | 17.68 | 33.2 | -18.68 | -2.78 | |||||
EBITDA, 1 Yr. Growth % | 11.45 | -8.35 | -2.04 | -31.09 | 31.25 | |||||
EBITA, 1 Yr. Growth % | 13.12 | -7.24 | -1.56 | -30.42 | 34.67 | |||||
EBIT, 1 Yr. Growth % | 13.12 | -7.24 | -1.56 | -30.42 | 34.67 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 4.89 | -2.49 | 3.12 | 15.04 | 15.04 | |||||
Net Income, 1 Yr. Growth % | 4.89 | -2.49 | 3.12 | 15.04 | 15.04 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.33 | -8.68 | -3.09 | -32.2 | 32.18 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 4.83 | -3.71 | -1.08 | 14.04 | 15.05 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.3 | 4.17 | 4.04 | 6.1 | 61.13 | |||||
Accounts Receivable, 1 Yr. Growth % | 79.61 | 60.24 | 23.86 | 57.78 | 18.49 | |||||
Total Assets, 1 Yr. Growth % | 35.86 | 28.43 | 7.43 | 22.02 | 15.44 | |||||
Common Equity, 1 Yr. Growth % | 26.93 | 80.71 | -16.78 | 12.88 | 10.15 | |||||
Tangible Book Value, 1 Yr. Growth % | 26.97 | 15.63 | 30.12 | 12.79 | 10.35 | |||||
Cash From Operations, 1 Yr. Growth % | 31.34 | -38.75 | 15.83 | 55.76 | 45.48 | |||||
Capital Expenditures, 1 Yr. Growth % | 58.65 | -7.47 | 54.62 | 55.24 | 121.2 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 303.52 | -53.29 | 85.35 | -58.58 | -366.9 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 300.13 | -51.64 | 84.41 | -56.81 | -338.4 | |||||
Dividend Per Share, 1 Yr. Growth % | - | -15.84 | 11.76 | 5.26 | 5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 36.69 | 52.87 | -0.82 | 22.79 | 17.19 | |||||
Gross Profit, 2 Yr. CAGR % | 8.08 | 12.99 | 25.2 | 4.08 | -11.08 | |||||
EBITDA, 2 Yr. CAGR % | 3.86 | 1.76 | -5.28 | -17.01 | -3.29 | |||||
EBITA, 2 Yr. CAGR % | 4.54 | 2.43 | -5.23 | -17.24 | -3.2 | |||||
EBIT, 2 Yr. CAGR % | 4.54 | 2.43 | -5.23 | -17.24 | -3.2 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.19 | 1.13 | 0.27 | 8.92 | 15.04 | |||||
Net Income, 2 Yr. CAGR % | 3.19 | 1.13 | 0.27 | 8.92 | 15.04 | |||||
Normalized Net Income, 2 Yr. CAGR % | 3.59 | 0.83 | -5.93 | -18.94 | -5.33 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 3.11 | 0.47 | -2.41 | 6.21 | 14.54 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.53 | 2.72 | 4.1 | 5.06 | 30.75 | |||||
Accounts Receivable, 2 Yr. CAGR % | 56.16 | 69.65 | 40.88 | 39.79 | 36.73 | |||||
Total Assets, 2 Yr. CAGR % | 17.54 | 32.1 | 17.46 | 14.54 | 18.68 | |||||
Common Equity, 2 Yr. CAGR % | 23.74 | 51.45 | 22.63 | -3.08 | 11.5 | |||||
Tangible Book Value, 2 Yr. CAGR % | 23.92 | 21.16 | 22.66 | 21.15 | 11.57 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.84 | -10.31 | -15.77 | 34.32 | 50.53 | |||||
Capital Expenditures, 2 Yr. CAGR % | 16.46 | 21.16 | 19.61 | 54.93 | 85.31 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 56.91 | 35.48 | -6.95 | -10.66 | 5.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 57.22 | 37.3 | -6.5 | -9.05 | 1.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.32 | - | -3.02 | 8.47 | 5.13 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 30.49 | 20.65 | 34.73 | 12.33 | 12.85 | |||||
Gross Profit, 3 Yr. CAGR % | 11.67 | 11.19 | 19.36 | 8.42 | 1.74 | |||||
EBITDA, 3 Yr. CAGR % | 7.86 | 0.07 | 0.46 | -14.24 | -2.23 | |||||
EBITA, 3 Yr. CAGR % | 8.48 | 0.46 | 0.53 | -14.51 | -2.65 | |||||
EBIT, 3 Yr. CAGR % | 8.48 | 0.46 | 0.53 | -14.51 | -2.65 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.12 | 1.26 | 1.79 | 4.97 | 10.92 | |||||
Net Income, 3 Yr. CAGR % | 7.12 | 1.26 | 1.79 | 4.97 | 10.92 | |||||
Normalized Net Income, 3 Yr. CAGR % | 7.79 | -0.68 | -0.5 | -15.65 | -4.59 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.02 | 0.78 | -0.05 | 2.79 | 9.08 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.12 | 2.4 | 3.16 | 4.77 | 21.16 | |||||
Accounts Receivable, 3 Yr. CAGR % | 30.03 | 57.51 | 52.76 | 46.3 | 32.3 | |||||
Total Assets, 3 Yr. CAGR % | 17.59 | 21.07 | 23.3 | 18.99 | 14.84 | |||||
Common Equity, 3 Yr. CAGR % | 22.19 | 40.39 | 24.05 | 19.29 | 1.14 | |||||
Tangible Book Value, 3 Yr. CAGR % | 22.45 | 21.09 | 24.08 | 19.28 | 17.44 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.92 | -15.55 | -2.33 | 3.38 | 37.94 | |||||
Capital Expenditures, 3 Yr. CAGR % | 21.8 | 7.86 | 31.42 | 30.47 | 74.46 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.88 | 3.85 | 50.4 | -28.03 | 28.69 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 7.3 | 5.21 | 50.49 | -26.8 | 25.42 | |||||
Dividend Per Share, 3 Yr. CAGR % | 14.1 | 1.41 | - | -0.33 | 7.3 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 31.66 | 17.08 | 16.93 | 21.5 | 27.42 | |||||
Gross Profit, 5 Yr. CAGR % | 16.76 | 15.93 | 16.9 | 8.29 | 6.1 | |||||
EBITDA, 5 Yr. CAGR % | 10.69 | 7.3 | 2.68 | -7.16 | -0.66 | |||||
EBITA, 5 Yr. CAGR % | 11.01 | 7.73 | 2.77 | -7.34 | -0.98 | |||||
EBIT, 5 Yr. CAGR % | 11.01 | 7.73 | 2.77 | -7.34 | -0.98 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.75 | 8.39 | 4.33 | 4.26 | 6.9 | |||||
Net Income, 5 Yr. CAGR % | 10.75 | 8.39 | 4.33 | 4.26 | 6.9 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.58 | 6.99 | 2.08 | -8.43 | -2.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.47 | 7.95 | 3.15 | 2.92 | 5.55 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.22 | 0.08 | 2.3 | 3.46 | 13.42 | |||||
Accounts Receivable, 5 Yr. CAGR % | 22.56 | 34.34 | 34.27 | 50.17 | 46.13 | |||||
Total Assets, 5 Yr. CAGR % | 18.6 | 19.4 | 17.54 | 18.41 | 21.45 | |||||
Common Equity, 5 Yr. CAGR % | 22.72 | 32.48 | 22.37 | 21.05 | 18.87 | |||||
Tangible Book Value, 5 Yr. CAGR % | 22.84 | 21.31 | 22.53 | 21.11 | 18.91 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.27 | -0.94 | 0.42 | 1.67 | 16.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.31 | 3.41 | 20.92 | 24.68 | 50.78 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.83 | -10.69 | 0.58 | -2.22 | 31.37 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.08 | -9.84 | 1.03 | -1.14 | 29.53 | |||||
Dividend Per Share, 5 Yr. CAGR % | 17.55 | 9.1 | 6.92 | 4.18 | - |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition